Answers are grounded in this paper and cite their sources.
Neurofibromatosis type 1 (NF1) predisposes to peripheral nerve sheath tumors arising from Schwann-lineage cells with biallelic NF1 loss and remains in need of biologically informed strategies compatible with chronic disease management. Curcumin has attracted interest in NF1, but its effects in disease-relevant cells remain unclear. Here, we investigated curcumin responses in patient-derived NF1-deficient Schwann cells. Curcumin induced the progressive accumulation of cytoplasmic vacuoles resembling those elicited by a reference methuosis inducer, without prominent evidence of canonical apoptotic features. Vacuolization was associated with impaired long-term clonogenic recovery, indicating a durable loss of proliferative fitness. NF1-deficient Schwann cells displayed lower levels of NRF2, thioredoxin, and SOD1 than NF1-proficient cells under basal and curcumin-treated conditions, defining a distinct NF1-associated antioxidant-response context. Consistent with a functionally relevant redox-sensitive component, N-acetylcysteine pretreatment reduced curcumin-induced vacuolization to near-basal levels and substantially improved clonogenic recovery after drug washout. NF1-proficient Schwann cells showed an attenuated vacuolizing response, whereas acute NF1 silencing in hTERT RPE-1 cells enhanced curcumin-induced vacuolization in an independent cellular background. Together, these findings identify an NAC-sensitive vacuolizing response associated with loss of cellular fitness as a previously underappreciated vulnerability of NF1-deficient cells and provide a disease-relevant framework for understanding curcumin responsiveness in NF1.
No takes yet. Share an insight, caveat, or question.
Iazzetta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: